BioAnalytix

company

About

BioAnalytix works with pharmaceutical partners for the development and commercialization of biologic and biosimilar drugs.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$3.75M
Industries
Biotechnology,Health Care,Health Diagnostics,Pharmaceutical
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

Bioanalytix is a pharmaceutically oriented commercial spin out from the Barnett institute of chemical and Biological Analysis at Northeastern university in Boston,MA. Founded by thought leaders in clinical development, regulatory strategy, and advanced analytics,Bioanaytix is working wiht leading Pharmaceutical partners to advance, improve and accelerate the development and commercialization of biologic and biosimilar drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.75M
BioAnalytix has raised a total of $3.75M in funding over 2 rounds. Their latest funding was raised on Oct 24, 2013 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 24, 2013 Series Unknown $3.75M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
BioAnalytix is funded by 1 investors. Relativity Healthcare Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Relativity Healthcare Partners Series Unknown